# OnCo record mt-304 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mt-304/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mt-304" ;
  schema:name "MT-304"@en ;
  schema:description "MT-304 is an experimental in vivo CAR therapy from CREATE Medicines, in phase 1 trials for solid tumours that carry HER2."@en ;
  schema:url <https://onco.cc/drugs/mt-304/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://createmedicines.com/>, <https://clinicaltrials.gov/study/NCT07334119> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "In vivo CAR therapy: mRNA in lipid nanoparticles that programmes NK and myeloid cells" ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:companies <https://onco.cc/companies/create-medicines/> ;
  onco:trials <https://onco.cc/trials/nct07334119/> .